This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Archer CB, Wells RS, MacDonald DM. Metastatic cutaneous carcinoid. J Am Acad Dermatol. 1985;13(2 Pt 2):363–6.
Bell HK, Poston GJ, Vora J, Wilson NJ. Cutaneous manifestations of the malignant carcinoid syndrome. Br J Dermatol. 2005;152(1):71–5.
Bolding J, Wratchford T, Perkins K, Ogershok P. Prevalence of obesity, acanthosis nigricans and hyperinsulinemia in an adolescent clinic. W V Med J. 2005;101(3):112–5.
Camisa C. Somatostatin and a long-acting analogue, octreotide acetate. Relevance to dermatology. Arch Dermatol. 1989;125(3):407–12.
Ersoy-Evans S, Sahin S, Mancini AJ, Paller AS, Guitart J. The acanthosis nigricans form of epidermal nevus. J Am Acad Dermatol. 2006;55(4):696–8.
Garcia Hidalgo L. Dermatological complications of obesity. Am J Clin Dermatol. 2002;3(7):497–506.
Green TPR. Scleroderma in association with carcinoid syndrome. Br J Dermatol. 1989;121(Suppl. 34):80.
Handley J, Walsh M, Armstrong K, Russell C, Buchanan K, Bingham A. Malignant carcinoid syndrome associated with cutaneous scleroderma. Br J Dermatol. 1993;129(2):222–3.
Jabbour SA, Davidovici BB, Wolf R. Rare syndromes. Clin Dermatol. 2006;24:299–316
Modlin IM, Shapiro MD, Kidd M. An analysis of rare carcinoid tumors: clarifying these clinical conundrums. World J Surg. 2005;29(1):92–101.
Pavlovic M, Saiag P, Lotz J P, Marinho E, Clerici T, Izrael V. Regression of sclerodermatous skin lesions in a patient with carcinoid syndrome treated by octreotide. Arch Dermatol. 1995;131(10):1207–9.
Ratnavel RC, Burrows NP, Pye RJ. Scleroderma and the carcinoid syndrome. Clin Exp Dermatol. 1994;19(1):83–5.
Rodriguez Trabado A, Riesco Miranda JA, Porcel Carreno S, Rodriguez Martin E, Fletes Peral C, Jimenez Timon S, Alvarado Arenas M, Hernandez Arbeiza J, Cobo Lopez R. Angioedema as a single manifestation of carcinoid syndrome in a bronchial carcinoid tumor. Allergol Immun- opathol (Madr). 2004;32(4):235–7.
Sitaraman S V, Goldfinger ST: The carcinoid syndrome. Uptodate (13.2) June 2005. (http://www.utdol. com).
Hermanns-Le T, Scheen A, Pierard GE. Acanthosis nigricans associated with insulin resistance: pathophysiology and management. Am J Clin Dermatol. 2004;5(3):199–203.
Lopez-Alvarenga JC, GarcÃa-Hidalgo L, Landa-Anell MV, Santos-Gómez R, González-Barranco J, Comuzzie A. Influence of skin color on the diagnostic utility of clinical acanthosis nigricans to predict insulin resistance in obese patients. Arch Med Res. 2006;37(6):744–8.
Mekhail TM, Markman M. Acanthosis nigricans with endometrial carcinoma: case report and review of the literature. Gynecol Oncol. 2002;84(2):332–4.
Selkin BA, Reynolds RV, Selkin G. Cutaneous manifestations of internal malignancy. UptoDate® 2005 (http://www.utdol.com).
Stone SP, Buescher LS. Life-threatening paraneoplastic cutaneous syndromes. Clin Dermatol. 2005;23:301–6.
Torley D, Bellus GA, Munro CS. Genes, growth factors and acanthosis nigricans. Br J Dermatol. 2002;147(6):1096–101.
Yosipovitch G, DeVore A, Dawn A. Obesity and the skin: skin physiology and skin manifestations of obesity. J Am Acad Dermatol. 2007;56(6):901–16; quiz 917–20.
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
(2009). Intestinal Hormones. In: Cutaneous Manifestations of Endocrine Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-88367-8_12
Download citation
DOI: https://doi.org/10.1007/978-3-540-88367-8_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-88366-1
Online ISBN: 978-3-540-88367-8
eBook Packages: MedicineMedicine (R0)